Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

724 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization.
Lamacchia G, Mazzoni A, Spinicci M, Vanni A, Salvati L, Peruzzi B, Bencini S, Capone M, Carnasciali A, Farahvachi P, Rocca A, Kiros ST, Graziani L, Zammarchi L, Mencarini J, Colao MG, Caporale R, Liotta F, Cosmi L, Rossolini GM, Bartoloni A, Maggi L, Annunziato F. Lamacchia G, et al. Among authors: mazzoni a. J Clin Immunol. 2022 Oct;42(7):1379-1391. doi: 10.1007/s10875-022-01325-2. Epub 2022 Jul 9. J Clin Immunol. 2022. PMID: 35809212 Free PMC article.
Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection.
Peruzzi B, Bencini S, Capone M, Mazzoni A, Maggi L, Salvati L, Vanni A, Orazzini C, Nozzoli C, Morettini A, Poggesi L, Pieralli F, Peris A, Bartoloni A, Vannucchi AM, Liotta F, Caporale R, Cosmi L, Annunziato F. Peruzzi B, et al. Among authors: mazzoni a. Immunology. 2020 Dec;161(4):345-353. doi: 10.1111/imm.13254. Epub 2020 Oct 6. Immunology. 2020. PMID: 32870529 Free PMC article.
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients.
Mazzoni A, Maggi L, Capone M, Spinicci M, Salvati L, Colao MG, Vanni A, Kiros ST, Mencarini J, Zammarchi L, Mantengoli E, Menicacci L, Caldini E, Romagnani S, Liotta F, Morettini A, Rossolini GM, Bartoloni A, Cosmi L, Annunziato F. Mazzoni A, et al. Eur J Immunol. 2020 Dec;50(12):2013-2024. doi: 10.1002/eji.202048915. Epub 2020 Nov 9. Eur J Immunol. 2020. PMID: 33080068 Free article. Clinical Trial.
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19.
Mazzoni A, Di Lauria N, Maggi L, Salvati L, Vanni A, Capone M, Lamacchia G, Mantengoli E, Spinicci M, Zammarchi L, Kiros ST, Rocca A, Lagi F, Colao MG, Parronchi P, Scaletti C, Turco L, Liotta F, Rossolini GM, Cosmi L, Bartoloni A, Annunziato F; COVID-19 Research Group. Mazzoni A, et al. J Clin Invest. 2021 Jun 15;131(12):e149150. doi: 10.1172/JCI149150. J Clin Invest. 2021. PMID: 33939647 Free PMC article.
Heterogeneous magnitude of immunological memory to SARS-CoV-2 in recovered individuals.
Mazzoni A, Maggi L, Capone M, Vanni A, Spinicci M, Salvati L, Tekle Kiros S, Semeraro R, Pengue L, Colao MG, Magi A, Rossolini GM, Liotta F, Cosmi L, Bartoloni A, Annunziato F. Mazzoni A, et al. Clin Transl Immunology. 2021 May 6;10(5):e1281. doi: 10.1002/cti2.1281. eCollection 2021. Clin Transl Immunology. 2021. PMID: 33976879 Free PMC article.
AIDS patient with severe T cell depletion achieved control but not clearance of SARS-CoV-2 infection.
Spinicci M, Mazzoni A, Borchi B, Graziani L, Mazzetti M, Bartalesi F, Botta A, Tilli M, Pieralli F, Coppi M, Giovacchini N, Colao MG, Saccardi R, Rossolini GM, Annunziato F, Bartoloni A. Spinicci M, et al. Among authors: mazzoni a. Eur J Immunol. 2022 Feb;52(2):352-355. doi: 10.1002/eji.202149574. Epub 2021 Dec 4. Eur J Immunol. 2022. PMID: 34822185 Free PMC article.
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies.
Mazzoni A, Vanni A, Spinicci M, Lamacchia G, Kiros ST, Rocca A, Capone M, Di Lauria N, Salvati L, Carnasciali A, Mantengoli E, Farahvachi P, Zammarchi L, Lagi F, Colao MG, Liotta F, Cosmi L, Maggi L, Bartoloni A, Rossolini GM, Annunziato F. Mazzoni A, et al. J Clin Invest. 2022 Mar 15;132(6):e157990. doi: 10.1172/JCI157990. J Clin Invest. 2022. PMID: 35139036 Free PMC article.
SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron.
Mazzoni A, Vanni A, Spinicci M, Capone M, Lamacchia G, Salvati L, Coppi M, Antonelli A, Carnasciali A, Farahvachi P, Giovacchini N, Aiezza N, Malentacchi F, Zammarchi L, Liotta F, Rossolini GM, Bartoloni A, Cosmi L, Maggi L, Annunziato F. Mazzoni A, et al. Front Immunol. 2022 Jan 26;13:801431. doi: 10.3389/fimmu.2022.801431. eCollection 2022. Front Immunol. 2022. PMID: 35154116 Free PMC article.
Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications.
Spinicci M, Mazzoni A, Coppi M, Antonelli A, Salvati L, Maggi L, Basile G, Graziani L, Di Lauria N, Di Pilato V, Kiros ST, Beccastrini E, Saccardi R, Angileri M, Cecchi M, Cusi MG, Rossolini GM, Annunziato F, Bartoloni A, Parronchi P. Spinicci M, et al. Among authors: mazzoni a. J Clin Immunol. 2022 Oct;42(7):1371-1378. doi: 10.1007/s10875-022-01313-6. Epub 2022 Jul 2. J Clin Immunol. 2022. PMID: 35779200 Free PMC article.
724 results